Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion.
暂无分享,去创建一个
K. Ker | B. Stokes | A. Moxey | D. Fergusson | D. Henry | P. Carless | D. O'connell
[1] O. Darçın,et al. Mini-Dose Pump-Prime Aprotinin Inhibited Enhanced Fibrinolytic Activity and Reduced Blood Loss and Transfusion Requirements After Coronary Artery Bypass Surgery , 2005, Journal of Thrombosis and Thrombolysis.
[2] H. Teufelsbauer,et al. Decreasing use of donated blood and reduction of bleeding after orthotopic heart transplantation by use of aprotinin. , 1992, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[3] C. Mélot,et al. Comparison of the effects of aprotinin and tranexamic acid on blood loss and red blood cell transfusion requirements during the late stages of liver transplantation , 2006, Transfusion.
[4] W. Kuebler,et al. Heparin-Level-Based Anticoagulation Management During Cardiopulmonary Bypass: A Pilot Investigation on the Effects of a Half-Dose Aprotinin Protocol on Postoperative Blood Loss and Hemostatic Activation and Inflammatory Response , 2004, Anesthesia and analgesia.
[5] J. Fontcuberta,et al. Aprotinin versus desmopressin for patients undergoing operations with cardiopulmonary bypass. A double-blind placebo-controlled study. , 1995, The Journal of thoracic and cardiovascular surgery.
[6] R. Delfino,et al. [Comparison between low and high doses of aprotinin in heart surgery]. , 1994, Minerva Anestesiologica.
[7] W. S. Beattie,et al. Con: Aprotinin has a good efficacy and safety profile relative to other alternatives for prevention of bleeding in cardiac surgery. , 2006, Anesthesia and analgesia.
[8] C. R. Smith,et al. Management of bleeding complications in redo cardiac operations. , 1998, The Annals of thoracic surgery.
[9] B. Chaitman,et al. Analyses of coronary graft patency after aprotinin use: results from the International Multicenter Aprotinin Graft Patency Experience (IMAGE) trial. , 1998, The Journal of thoracic and cardiovascular surgery.
[10] J. Paramo,et al. Randomized Study of Aprotinin and DDAVP to Reduce Postoperative Bleeding After Cardiopulmonary Bypass Surgery , 1994, Circulation.
[11] J. Carroll,et al. Prevention of bleeding after cardiopulmonary bypass with high-dose tranexamic acid. Double-blind, randomized clinical trial. , 1995, The Journal of thoracic and cardiovascular surgery.
[12] M. Ray,et al. Comparison of epsilon aminocaproic acid and low-dose aprotinin in cardiopulmonary bypass: efficiency, safety and cost. , 2001, The Annals of thoracic surgery.
[13] A. Barnett,et al. How To Do Safe Sternal Reentry and the Risk Factors of Redo Cardiac Surgery: A 21‐Year Review with Zero Major Cardiac Injury , 2001, Journal of cardiac surgery.
[14] G. Gravlee,et al. Tranexamic Acid Reduces Bleeding After Cardiopulmonary Bypass When Compared to Epsilon Aminocaproic Acid and Placebo , 1997, Journal of cardiac surgery.
[15] J. Magaziner,et al. A pilot randomized trial comparing symptomatic vs. hemoglobin‐level‐ driven red blood cell transfusions following hip fracture , 1998, Transfusion.
[16] G. Walker,et al. Tranexamic acid reduces early post-operative blood loss after total knee arthroplasty: a prospective randomised controlled trial of 29 patients. , 2006, The Knee.
[17] M. Jessen,et al. Aprotinin But Not &egr;-Aminocaproic Acid Decreases Interleukin-10 After Cardiac Surgery With Extracorporeal Circulation: Randomized, Double-Blind, Placebo-Controlled Study in Patients Receiving Aprotinin and &egr;-Aminocaproic Acid , 2001, Circulation.
[18] L. Blønd,et al. Tranexamic acid reduces blood loss and blood transfusions in primary total hip arthroplastyA prospective randomized double-blind study in 40 patients , 2003, Acta orthopaedica Scandinavica.
[19] R. E. Clark,et al. A multicenter, double-blind, placebo-controlled trial of aprotinin for reducing blood loss and the requirement for donor-blood transfusion in patients undergoing repeat coronary artery bypass grafting. , 1995, Circulation.
[20] E. Vamvakas,et al. Deleterious clinical effects of transfusion-associated immunomodulation: fact or fiction? , 2001, Blood.
[21] G. Calori,et al. Hemostatic effects of tranexamic acid in elective thoracic aortic surgery: a prospective, randomized, double-blind, placebo-controlled study. , 2002, The Journal of thoracic and cardiovascular surgery.
[22] D. V. Van Riper,et al. Hemostatic Effects of Tranexamic Acid and Desmopressin During Cardiac Surgery , 1991, Circulation.
[23] J. Vinnicombe,et al. Aminocaproic acid in the control of haemorrhage after prostatectomy. Safety of aminocaproic acid--a controlled trial. , 1966, Lancet.
[24] G. Escolar,et al. Platelet function during cardiac surgery and cardiopulmonary bypass with low-dose aprotinin. , 1999, Journal of cardiothoracic and vascular anesthesia.
[25] R. Martineau,et al. A comparison of aprotinin and lysine analogues in high-risk cardiac surgery. , 2008, The New England journal of medicine.
[26] J. Horrow,et al. The Dose-Response Relationship of Tranexamic Acid , 1995 .
[27] W. van Oeveren,et al. Aprotinin reduces intraoperative and postoperative blood loss in membrane oxygenator cardiopulmonary bypass. , 1991, The Annals of thoracic surgery.
[28] H. Lummis,et al. The use of low-dose aprotinin, epsilon-aminocaproic acid or tranexamic acid for prevention of mediastinal bleeding in patients receiving aspirin before coronary artery bypass operations. , 1997, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[29] L. Eijsman,et al. Hemostatic efficacy of dipyridamole, tranexamic acid, and aprotinin in coronary bypass grafting. , 1995, The Annals of thoracic surgery.
[30] G. Nuttall,et al. Comparison of Blood-conservation Strategies in Cardiac Surgery Patients at High Risk for Bleeding , 2000, Anesthesiology.
[31] Liu Yc,et al. The effect of coagulation protection with combination of epsilon aminocaproic acid and plasma saver in open-heart surgery. , 1998 .
[32] Arthur S Slutsky,et al. Transfusion requirements in critical care : a pilot study , 1995 .
[33] S. Kleinman,et al. A Multicenter, Randomized, Controlled Clinical Trial of Transfusion Requirements in Critical Care , 1999 .
[34] B. Lassale,et al. Aprotinine au cours des transplantations hépatiques : intérêt clinique et économique sur les besoins transfusionnels , 1996 .
[35] K. M. Taylor,et al. EFFECT OF APROTININ ON NEED FOR BLOOD TRANSFUSION AFTER REPEAT OPEN-HEART SURGERY , 1987, The Lancet.
[36] E. Struck,et al. Efficacy of Aprotinin in Different Doses and Autologous Blood Transfusions in Cardiac Surgery , 1994, Cardiovascular surgery.
[37] T. Carrel,et al. Aprotinin reduces blood loss in off-pump coronary artery bypass (OPCAB) surgery. , 2002, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[38] N. Laird,et al. Meta-analysis in clinical trials. , 1986, Controlled clinical trials.
[39] X. Moreau,et al. Comparaison des effets de l’aprotinine et de l’acide tranexamique sur le saignement en chirurgie cardiaque , 1995 .
[40] M. Haller,et al. Does Aprotinin Really Reduce Blood Loss in Orthotopic Liver Transplantation? , 1993, Seminars in thrombosis and hemostasis.
[41] D. Loisance,et al. [Reduction of per- and postoperative blood loss with aprotinin (Trasylol) during extracorporeal circulation]. , 1991, Archives des maladies du coeur et des vaisseaux.
[42] T. Brewer,et al. The problem of transfusion-associated acquired immunodeficiency syndrome in Africa: a quantitative approach. , 1992, American journal of infection control.
[43] D. E. Harmon. Cost/benefit analysis of pharmacologic hemostasis. , 1996, The Annals of thoracic surgery.
[44] A. Starr,et al. Reduction in costs, blood products, and operating time in patients undergoing open heart surgery. , 1997, Archives of surgery.
[45] A. Hussain,et al. Effect of aprotinin on plasma fibronectin levels during cardiopulmonary bypass. , 1997, The Annals of thoracic surgery.
[46] H. Gayle,et al. International aspects of the AIDS/HIV epidemic. , 1995, Annual review of public health.
[47] O. Alfieri,et al. Effects of tranexamic acid on postoperative bleeding and related hematochemical variables in coronary surgery: Comparison between on-pump and off-pump techniques. , 2004, The Journal of thoracic and cardiovascular surgery.
[48] G. Hempelmann,et al. Blood conservation techniques and platelet function in cardiac surgery. , 1991, Anesthesiology.
[49] M. Serra-Prat,et al. Efficacy of aminocaproic, tranexamic acids in the control of bleeding during total knee replacement: a randomized clinical trial. , 2006, British journal of anaesthesia.
[50] J. Field,et al. Bone bleeding during total hip arthroplasty after administration of tranexamic acid. , 2004, The Journal of arthroplasty.
[51] G. Friedel,et al. Reduced blood loss by aprotinin in thoracic surgical operations associated with high risk of bleeding. A placebo-controlled, randomized phase IV study. , 2001, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[52] O. Alfieri,et al. Hemostatic effects of aprotinin, tranexamic acid and ϵ-aminocaproic acid in primary cardiac surgery , 1999 .
[53] H. Fredin,et al. Blood conservation with tranexamic acid in total hip arthroplasty: A randomized, double-blind study in 40 primary operations , 2001, Acta orthopaedica Scandinavica.
[54] D. Cosgrove,et al. Reduction in blood loss and blood use after cardiopulmonary bypass with high dose aprotinin (Trasylol). , 1989, The Journal of thoracic and cardiovascular surgery.
[55] B. Lisander,et al. Tranexamic acid in total hip arthroplasty saves blood and money , 2005, Acta orthopaedica.
[56] H. Savoia,et al. The risk of transmitting HCV, HBV or HIV by blood transfusion in Victoria , 1997, The Medical journal of Australia.
[57] M. Abdelnoor,et al. Tranexamic acid (Cyklokapron) is not necessary to reduce blood loss after coronary artery bypass operations. , 1993, The Journal of thoracic and cardiovascular surgery.
[58] G. Nuttall,et al. The Effect of Epsilon-Aminocaproic Acid and Aprotinin on Fibrinolysis and Blood Loss in Patients Undergoing Primary, Isolated Coronary Artery Bypass Surgery: A Randomized, Double-Blind, Placebo-Controlled, Noninferiority Trial , 2009, Anesthesia and analgesia.
[59] J. D'haese,et al. Use of tranexamic acid for an effective blood conservation strategy after total knee arthroplasty. , 1999, British journal of anaesthesia.
[60] M. O. Ersoy,et al. The effects of aprotinin and steroids on generation of cytokines during coronary artery surgery. , 2001, Journal of cardiothoracic and vascular anesthesia.
[61] G. Lemole,et al. Prophylactic treatment of postperfusion bleeding using EACA. , 1989, Chest.
[62] A. Sturk,et al. Low-dose and high-dose aprotinin improve hemostasis in coronary operations. , 1996, The Journal of thoracic and cardiovascular surgery.
[63] S. Molliex,et al. Tranexamic acid in hip fracture surgery: a randomized controlled trial. , 2010, British journal of anaesthesia.
[64] J. Weill. [Hemostatic drugs]. , 1957, Strasbourg medical.
[65] M. Toungouz,et al. Effect of Two Different Dosages of Aprotonin on Perioperative Blood Loss during Liver Transplantation , 1993, Seminars in thrombosis and hemostasis.
[66] G. Dangas,et al. Fibrinolytic activity and bleeding after cardiac surgery with cardiopulmonary bypass and low-dose aprotinin therapy , 2003, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.
[67] J. Gill,et al. The use of tranexamic acid in revision total hip arthroplasty: a pilot study , 2009 .
[68] H. Eisen,et al. Defining the role of aprotinin in heart transplantation. , 1996, The Annals of thoracic surgery.
[69] R. Schall,et al. High-dose Aprotinin in Cardiac Surgery—A Prospective, Randomized Study , 1994, Anaesthesia and intensive care.
[70] W. Kucharczyk,et al. Tranexamic acid and early saphenous vein graft patency in conventional coronary artery bypass graft surgery: a prospective randomized controlled clinical trial. , 2005, The Journal of thoracic and cardiovascular surgery.
[71] C. Ecoffey,et al. Comparative Effects of Small and Large Aprotinin Doses on Bleeding During Orthotopic Liver Transplantation , 1995, Anesthesia and analgesia.
[72] M. Logan,et al. Use of aprotinin in knee replacement surgery. , 1994, British journal of anaesthesia.
[73] D. Amar,et al. Antifibrinolytic Therapy and Perioperative Blood Loss in Cancer Patients Undergoing Major Orthopedic Surgery , 2003, Anesthesiology.
[74] P. Wouters,et al. Aprotinin reduces cardiac troponin I release and inhibits apoptosis of polymorphonuclear cells during off-pump coronary artery bypass surgery. , 2008, Journal of cardiothoracic and vascular anesthesia.
[75] A. Tonkin,et al. Aspirin and Tranexamic Acid for Coronary Artery Surgery (ATACAS) Trial: rationale and design. , 2008, American heart journal.
[76] G. Çağlar,et al. Intravenous tranexamic acid use in myomectomy: a prospective randomized double-blind placebo controlled study. , 2008, European journal of obstetrics, gynecology, and reproductive biology.
[77] A. Stern,et al. The Postoperative Blood-Sparing Efficacy of Oral Versus Intravenous Tranexamic Acid After Total Knee Replacement , 2004, Anesthesia and analgesia.
[78] O. Šimić,et al. Re-graft patency and clinical efficacy of aprotinin in elective bypass surgery. , 1997, Cardiovascular surgery.
[79] P. Pronovost,et al. Effect of Epsilon Aminocaproic Acid on Red-Cell Transfusion Requirements in Major Spinal Surgery , 2009, Spine.
[80] J. Pincemail,et al. Cytokine release and neutrophil activation are not prevented by heparin-coated circuits and aprotinin administration. , 2000, The Annals of thoracic surgery.
[81] M. Nakajima,et al. Additional postbypass administration of tranexamic acid reduces blood loss after cardiac operations. , 1997, The Journal of thoracic and cardiovascular surgery.
[82] F. Loop,et al. Aprotinin therapy for reoperative myocardial revascularization: a placebo-controlled study. , 1992, The Annals of thoracic surgery.
[83] Luo Jun,et al. Effect of aprotinin on the red cell immunity in cardiopulmonary bypass , 2008, Journal of Tongji Medical University.
[84] D. Palanzo,et al. The effect of low-dose epsilon-aminocaproic acid on patients following coronary artery bypass surgery , 1996, Perfusion.
[85] V. Rasi,et al. The effects of aprotinin and tranexamic acid on thrombin generation and fibrinolytic response after cardiac surgery , 2005, Acta anaesthesiologica Scandinavica.
[86] J. Rumberger,et al. Aprotinin for coronary artery bypass grafting: effect on postoperative renal function. , 1995, The Annals of thoracic surgery.
[87] K. Watterson,et al. "Low-dose" aprotinin modifies hemostasis but not proinflammatory cytokine release. , 1997, The Annals of thoracic surgery.
[88] R. Sladen,et al. The Effects of epsilon-Aminocaproic Acid on Fibrinolysis and Thrombin Generation During Cardiac Surgery , 1997, Anesthesia and analgesia.
[89] J. Field,et al. Aprotinin (Trasylol) does not reduce bleeding in primary total hip arthroplasty. , 2000, The Journal of arthroplasty.
[90] M. Ray,et al. Preoperative platelet dysfunction increases the benefit of aprotinin in cardiopulmonary bypass. , 1997, The Annals of thoracic surgery.
[91] G. Hill,et al. Methylprednisolone and full-dose aprotinin reduce reperfusion injury after cardiopulmonary bypass. , 1997, Journal of cardiothoracic and vascular anesthesia.
[92] M. Bellamy,et al. Tranexamic acid reduces blood loss during orthotopic liver transplantation , 1993 .
[93] T. Carrel,et al. Aprotinin in coronary operation with cardiopulmonary bypass: does "low-dose" aprotinin inhibit the inflammatory response? , 2002, The Annals of thoracic surgery.
[94] E. Struck,et al. Consequences of a combined administration of different doses of aprotinin and autologous blood transfusions for coagulation and fluid replacement in cardiac surgery. , 1994, The Journal of cardiovascular surgery.
[95] M. Ray,et al. Economic evaluation of high-dose and low-dose aprotinin therapy during cardiopulmonary bypass. , 1999, The Annals of thoracic surgery.
[96] A. Laupacis,et al. Drugs to Minimize Perioperative Blood Loss in Cardiac Surgery: Meta-Analyses Using Perioperative Blood Transfusion As the Outcome , 1997, Anesthesia and analgesia.
[97] O. Alfieri,et al. Tranexamic acid compared with high-dose aprotinin in primary elective heart operations: effects on perioperative bleeding and allogeneic transfusions. , 2000, The Journal of thoracic and cardiovascular surgery.
[98] B. Garayar,et al. Comparison of two doses of aprotinin in patients receiving aspirin before coronary bypass surgery , 2000, Perfusion.
[99] S. Lethagen,et al. Tranexamic acid, given at the end of the operation, does not reduce postoperative blood loss in hip arthroplasty , 2000, Acta orthopaedica Scandinavica.
[100] J. DiMaio,et al. Antifibrinolytic therapy during cardiopulmonary bypass reduces proinflammatory cytokine levels: a randomized, double-blind, placebo-controlled study of epsilon-aminocaproic acid and aprotinin. , 2003, The Journal of thoracic and cardiovascular surgery.
[101] G. Fraedrich,et al. Reduction of Blood Transfusion Requirement in Open Heart Surgery by Administration of High Doses of Aprotinin - Preliminary Results , 1989, The Thoracic and cardiovascular surgeon.
[102] R. Kallen,et al. Tranexamic acid as an aid to reducing blood transfusion requirements in gastric and duodenal bleeding. , 1987, British medical journal.
[103] J. Guay,et al. Tranexamic acid reduces the need for allogenic red blood cell transfusions in patients undergoing total hip replacement , 2004, Canadian journal of anaesthesia = Journal canadien d'anesthesie.
[104] L. Cohn,et al. Aprotinin in primary valve replacement and reconstruction: a multicenter, double-blind, placebo-controlled trial. , 1996, The Journal of thoracic and cardiovascular surgery.
[105] R. Kalil,et al. A randomized, double-blind, and placebo-controlled study with tranexamic acid of bleeding and fibrinolytic activity after primary coronary artery bypass grafting. , 2006, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.
[106] B. Medalion,et al. Tranexamic acid reduces bleeding and the need for blood transfusion in primary myocardial revascularization. , 2002, The Annals of thoracic surgery.
[107] Cheng‐Chung Wu,et al. Perioperative Parenteral Tranexamic Acid in Liver Tumor Resection: A Prospective Randomized Trial Toward a “Blood Transfusion”-Free Hepatectomy , 2006, Annals of surgery.
[108] U. Demirkılıç,et al. Postoperative aprotinin: effect on blood loss and transfusion requirements in cardiac operations. , 1996, The Annals of thoracic surgery.
[109] S. McCluskey,et al. The independent association of massive blood loss with mortality in cardiac surgery. , 2005 .
[110] Flordal Pa. Pharmacological prophylaxis of bleeding in surgical patients treated with aspirin. , 1997 .
[111] A. Crosta,et al. Postoperative bleeding after coronary revascularization. Comparison between tranexamic acid and epsilon-aminocaproic acid. , 2000, Minerva cardioangiologica.
[112] A. Stewart,et al. Aprotinin reduces blood loss and the need for transfusion in orthognathic surgery. , 2001, The British journal of oral & maxillofacial surgery.
[113] T. Treasure,et al. Effect of aprotinin on clinical outcomes in coronary artery bypass graft surgery: a systematic review and meta-analysis of randomized clinical trials. , 2004, The Journal of thoracic and cardiovascular surgery.
[114] J. A. Hickman,et al. The effect of the fibrinolytic inhibitor epsilonaminocaproic acid on the incidence of deep‐vein thrombosis after prostatectomy , 1972, The British journal of surgery.
[115] Does acute normovolemic hemodilution reduce perioperative allogeneic transfusion? A meta-analysis. The International Study of Perioperative Transfusion. , 1998, Anesthesia and analgesia.
[116] D. Taggart,et al. A randomized trial of aprotinin (Trasylol) on blood loss, blood product requirement, and myocardial injury in total arterial grafting. , 2003, The Journal of thoracic and cardiovascular surgery.
[117] K. Skarvan,et al. Reduction of Blood Loss and Transfusion Requirements After Coronary Artery Bypass Grafting: , 1999 .
[118] M. Rossi,et al. A pump-prime aprotinin dose in cardiac surgery: appraisal of its effects on the hemostatic system. , 1997, Journal of Cardiothoracic and Vascular Anesthesia.
[119] S. Pugh,et al. A comparison of the effects of tranexamic acid and low-dose aprotinin on blood loss and homologous blood usage in patients undergoing cardiac surgery. , 1995, Journal of cardiothoracic and vascular anesthesia.
[120] M. Sadeghi,et al. DOES A SINGLE BOLUS DOSE OF TRANEXAMIC ACID REDUCE BLOOD LOSS AND TRANSFUSION REQUIREMENTS DURING HIP FRACTURE SURGERY? A PROSPECTIVE RANDOMEZED DOUBLE BLIND STUDY IN 67 PATIENTS , 2007 .
[121] P. Haentjens,et al. Reduction of Blood Loss with Tranexamic Acid in Primary Total Hip Replacement Surgery , 2007, Acta chirurgica Belgica.
[122] G. Hempelmann,et al. Does aprotinin influence endothelial-associated coagulation in cardiac surgery? , 1994, Journal of cardiothoracic and vascular anesthesia.
[123] J. E. Doran,et al. Comparison of the effects of aprotinin and tranexamic acid on blood loss and related variables after cardiopulmonary bypass. , 1994, The Journal of thoracic and cardiovascular surgery.
[124] S. Popelka,et al. [Aprotinin (Antilysin Spofa)--its effect on decreasing hemorrhage in the postoperative period in hip arthroplasty]. , 2001, Acta chirurgiae orthopaedicae et traumatologiae Cechoslovaca.
[125] R. Hall,et al. Aprotinin Decreases Exposure to Allogeneic Blood During Primary Unilateral Total Hip Replacement* , 2000, The Journal of bone and joint surgery. American volume.
[126] M. McCarroll,et al. The efficacy of single-dose aprotinin 2 million KIU in reducing blood loss and its impact on the incidence of deep venous thrombosis in patients undergoing total hip replacement surgery. , 1996, Journal of clinical anesthesia.
[127] C. Greenberg,et al. Antifibrinolytic drugs and perioperative hemostasis , 1997, American journal of hematology.
[128] Zhigang Guo,et al. Tranexamic acid reduces postoperative bleeding in off-pump coronary artery bypass grafting , 2006, Scandinavian cardiovascular journal : SCJ.
[129] A. Hoeft,et al. Mortality associated with aprotinin during 5 years following coronary artery bypass graft surgery. , 2007, JAMA.
[130] B. Smith,et al. Effects of (cid:1) -Aminocaproic Acid and Aprotinin on Leukocyte–Platelet Adhesion in Patients Undergoing Cardiac Surgery , 2022 .
[131] G. Mayer,et al. Aprotinin counterbalances an increased risk of peri-operative hemorrhage in CABG patients pre-treated with Aspirin. , 1998, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[132] A. R. Marchese,et al. Suppressed fibrinolysis after administration of low-dose aprotinin: reduced level of plasmin-alpha2-plasmin inhibitor complexes and postoperative blood loss. , 1995, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[133] G. Schmitz,et al. Aprotinin Has no Effect on Platelet Activation and Adhesion during Cardiopulmonary Bypass , 1996, Thrombosis and Haemostasis.
[134] E. F. Bruggemans,et al. Tranexamic acid and aprotinin in low- and intermediate-risk cardiac surgery: a non-sponsored, double-blind, randomised, placebo-controlled trial. , 2009, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[135] C. Atalay,et al. Effects of Aprotinin on Plasma Levels of Neutrophil Elastase and Postoperative Blood Loss in Cardiac Surgery , 1996, Cardiovascular surgery.
[136] S. Body,et al. Pro: Aprotinin Has a Good Efficacy and Safety Profile Relative to Other Alternatives for Prevention of Bleeding in Cardiac Surgery , 2006, Anesthesia and analgesia.
[137] R. J. Hayes,et al. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. , 1995, JAMA.
[138] T. Gherli,et al. [Reducing bleeding during extracorporeal circulation interventions by high doses of aprotinin]. , 1992, Minerva cardioangiologica.
[139] J. Fontcuberta,et al. The effect of two different doses of aprotinin on hemostasis in cardiopulmonary bypass surgery: similar transfusion requirements and blood loss. , 2000, Haematologica.
[140] G. E. Fernandez,et al. Aprotinin Effects Related to Oxidative Stress in Cardiosurgery with Mechanical Cardiorespiratory Support (CMCS) , 1996, Annals of the New York Academy of Sciences.
[141] M. Jochum,et al. Influence of high- and low-dose aprotinin on activation of hemostasis in open heart operations. , 1998, The Annals of thoracic surgery.
[142] G. Chiaudani,et al. [Aprotinin in cardiosurgery: a randomized prospective study with different protocols for use]. , 1990, Minerva anestesiologica.
[143] S. Fremes,et al. Aprotinin and tranexamic acid for high transfusion risk cardiac surgery. , 2000, The Annals of thoracic surgery.
[144] J. Takala,et al. Hydroxyethyl starches: what do we still know? , 2011, Anesthesia and analgesia.
[145] R. Parvizi,et al. Ultra-low dose aprotinin effects on reducing the need for blood transfusion in cardiac surgery. , 2007, Saudi medical journal.
[146] A. Hannekum,et al. Aprotinin in elective primary bypass surgery. Graft patency and clinical efficacy. , 1995, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[147] P. Mongan,et al. Tranexamic Acid and Aprotinin Reduce Postoperative Bleeding and Transfusions During Primary Coronary Revascularization , 1998, Anesthesia and analgesia.
[148] A. Christodoulou,et al. Does aprotinin reduce blood loss in total hip arthroplasty? , 2006, Orthopedics.
[149] M. Kikura,et al. A double-blind, placebo-controlled trial of epsilon-aminocaproic acid for reducing blood loss in coronary artery bypass grafting surgery. , 2006, Journal of the American College of Surgeons.
[150] A. B. Stewart,et al. ε-aminocaproic Acid in Coronary Artery Bypass Graft SurgeryPreincision or Postheparin? , 2003 .
[151] J. L. Iribarren,et al. Tranexamic acid attenuates inflammatory response in cardiopulmonary bypass surgery through blockade of fibrinolysis: a case control study followed by a randomized double-blind controlled trial , 2007, Critical care.
[152] E. Jaurrieta,et al. The prophylactic use of tranexamic acid and aprotinin in orthotopic liver transplantation: A comparative study , 2004, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[153] B. Stokes,et al. Are antifibrinolytic drugs equivalent in reducing blood loss and transfusion in cardiac surgery? A meta-analysis of randomized head-to-head trials , 2005 .
[154] Keyvan Karkouti,et al. A propensity score case‐control comparison of aprotinin and tranexamic acid in high‐transfusion‐risk cardiac surgery , 2006, Transfusion.
[155] G. Guiraudon,et al. Aprotinin significantly decreases bleeding and transfusion requirements in patients receiving aspirin and undergoing cardiac operations. , 1994, The Journal of thoracic and cardiovascular surgery.
[156] H. Riess,et al. DIFFERENT APROTININ APPLICATIONS INFLUENCING HEMOSTATIC CHANGES IN ORTHOTOPIC LIVER TRANSPLANTATION , 1992, Transplantation.
[157] A. Nadazdin. Book reviews : Wilde P et al. 1989: Doppler echocardiography, a clinical guide. London: Churchill Livingstone. 168pp; 270 ill. £29.95 , 1990 .
[158] I. C. Tudor,et al. The risk associated with aprotinin in cardiac surgery. , 2006, The New England journal of medicine.
[159] A. Trepanier,et al. Autologous donation error rates in Canada , 1997, Transfusion.
[160] F. Madsen,et al. Tranexamic acid given intraoperatively reduces blood loss after total knee replacement: a randomized, controlled study , 2002, Acta anaesthesiologica Scandinavica.
[161] A R Jadad,et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? , 1996, Controlled clinical trials.
[162] S. Ishii,et al. Timing of the administration of tranexamic acid for maximum reduction in blood loss in arthroplasty of the knee. , 2001, The Journal of bone and joint surgery. British volume.
[163] A. Laupacis,et al. Preoperative autologous donation decreases allogeneic transfusion but increases exposure to all red blood cell transfusion: results of a meta-analysis. International Study of Perioperative Transfusion (ISPOT) Investigators. , 1998, Archives of internal medicine.
[164] N. Hayashida,et al. Effects of minimal-dose aprotinin on coronary artery bypass grafting. , 1997, Journal of Thoracic and Cardiovascular Surgery.
[165] X. Capdevila,et al. Aprotinin Decreases Blood Loss and Homologous Transfusions in Patients Undergoing Major Orthopedic Surgery , 1998, Anesthesiology.
[166] M. Lamy,et al. High‐dose Aprotinin Reduces Blood Loss in Patients Undergoing Total Hip Replacement Surgery , 1994, Anesthesiology.
[167] C. Watala,et al. Low doses of aprotinin in aortocoronary bypass surgery--advantages and disadvantages. , 2000, Medical science monitor : international medical journal of experimental and clinical research.
[168] D. Roberts,et al. Half-dose aprotinin preserves hemostatic function in patients undergoing bypass operations. , 1995, The Annals of thoracic surgery.
[169] J. Ikonomidis,et al. Differential Effects of Epsilon-aminocaproic Acid and Aprotinin on Matrix Metalloproteinase Release in Patients Following Cardiopulmonary Bypass , 2008, Journal of cardiovascular pharmacology.
[170] R. Dirksen,et al. Reduction of blood loss using high-dose aprotinin in major orthopaedic surgery , 2004 .
[171] M. Frambach,et al. Influence of High-Dose Aprotinin on Hemostasis and Blood Requirement in Orthotopic Liver Transplantation , 1993, Seminars in thrombosis and hemostasis.
[172] M. Bigdeli,et al. The effect of tranexamic acid on reducing blood loss in cementless total hip arthroplasty under epidural anesthesia. , 2013, Orthopedics.
[173] O. Korkala,et al. Tranexamic acid reduces blood loss in cemented hip arthroplasty: A randomized, double-blind study of 39 patients with osteoarthritis , 2005, Acta orthopaedica.
[174] U. Demirkılıç,et al. Postoperative use of aprotinin in cardiac operations: an alternative to its prophylactic use. , 1996, The Journal of thoracic and cardiovascular surgery.
[175] H. Teufelsbauer,et al. Aprotinin does not decrease early graft patency after coronary artery bypass grafting despite reducing postoperative bleeding and use of donated blood. , 1994, The Journal of thoracic and cardiovascular surgery.
[176] V. Boddi,et al. High-dose aprotinin: hemostatic effects in open heart operations. , 1989, The Annals of thoracic surgery.
[177] T. Ferguson. Aprotinin--are there lessons learned? , 2007, JAMA.
[178] T. Schuster,et al. Tranexamic Acid and Aprotinin in Primary Cardiac Operations: An Analysis of 220 Cardiac Surgical Patients Treated with Tranexamic Acid or Aprotinin , 2008, Anesthesia and analgesia.
[179] R. Sapsford,et al. Aprotinin in aspirin-pretreated patients , 1990 .
[180] W. Dietrich,et al. High-dose aprotinin in cardiac surgery: three years' experience in 1,784 patients. , 1992, Journal of cardiothoracic and vascular anesthesia.
[181] J. Birkmeyer,et al. Is epsilon-aminocaproic acid as effective as aprotinin in reducing bleeding with cardiac surgery?: a meta-analysis. , 1999, Circulation.
[182] D. Harmon,et al. Aprotinin decreases the incidence of cognitive deficit following CABG and cardiopulmonary bypass: A pilot randomized controlled study , 2004, Canadian journal of anaesthesia = Journal canadien d'anesthesie.
[183] W. White,et al. Cost‐Benefit and Efficacy of Aprotinin Compared with ε‐Aminocaproic Acid in Patients Having Repeated Cardiac Operations: A Randomized, Blinded Clinical Trial , 1997 .
[184] M. Drent,et al. Too few, too late: submission patterns of bronchoalveolar lavage fluid samples obtained under the suspicion of the diagnosis of ventilator-associated pneumonia , 2006, Critical Care.
[185] H. Huwer,et al. Is there a phase of hypercoagulability when aprotinin is used in cardiac surgery? , 1994, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[186] O. Dale,et al. Single-Dose Tranexamic Acid Reduces Postoperative Bleeding After Coronary Surgery in Patients Treated with Aspirin Until Surgery , 2003, Anesthesia and analgesia.
[187] M. Maddali,et al. Tranexamic Acid and Primary Coronary Artery Bypass Surgery: A Prospective Study , 2007, Asian cardiovascular & thoracic annals.
[188] P. Thall,et al. A possible association between aprotinin and improved survival after radical surgery for mesothelioma , 2009, Cancer.
[189] M. Ray,et al. Aprotinin and epsilon aminocaproic acid are effective in reducing blood loss after primary total hip arthroplasty – a prospective randomized double‐blind placebo‐controlled study , 2005, Journal of thrombosis and haemostasis : JTH.
[190] F. Nurözler,et al. Aprotinin for Patients Exposed to Clopidogrel before Off-Pump Coronary Bypass , 2008, Asian cardiovascular & thoracic annals.
[191] J. Fortenberry,et al. Modifying risk for extracorporeal circulation: trial of four antiinflammatory strategies. , 1998, The Annals of thoracic surgery.
[192] M. Ramsay,et al. Continuous Small-Dose Tranexamic Acid Reduces Fibrinolysis but not Transfusion Requirements During Orthotopic Liver Transplantation , 1997, Anesthesia and analgesia.
[193] G. Vlahakes,et al. THE EFFECT OF PERIOPERATIVE ADMINISTRATION OF RECOMBINANT HUMAN ERYTHROPOIETIN (r-HuEPO) IN CABG PATIENTS: A DOUBLE BLIND, PLACEBO-CONTROLLED TRIAL , 1992 .
[194] A. Laupacis,et al. Adverse effects of methods for minimizing perioperative allogeneic transfusion: a critical review of the literature. , 1998, Transfusion medicine reviews.
[195] H. Miyawaki,et al. [Aprotinin 2 million KIU reduces perioperative blood loss in patients undergoing primary total hip replacement]. , 1997, Masui. The Japanese journal of anesthesiology.
[196] John D. Birkmeyer,et al. Is ε-Aminocaproic Acid as Effective as Aprotinin in Reducing Bleeding With Cardiac Surgery? A Meta-Analysis , 1999 .
[197] L. Lindgren,et al. Aprotinin and transfusion requirements in orthotopic liver transplantation: a multicentre randomised double-blind study , 2000, The Lancet.
[198] C. Long,et al. Combination of acute preoperative plateletpheresis, cell salvage, and aprotinin minimizes blood loss and requirement during cardiac surgery. , 2005, The journal of extra-corporeal technology.
[199] J. Smolich,et al. Low-dose postoperative aprotinin reduces mediastinal drainage and blood product use in patients undergoing primary coronary artery bypass grafting who are taking aspirin: a prospective, randomized, double-blind, placebo-controlled trial. , 2001, The Journal of thoracic and cardiovascular surgery.
[200] D. Roberts,et al. Effect of reduced aprotinin dosage on blood loss and use of blood products in patients undergoing cardiopulmonary bypass. , 1993, Scandinavian journal of thoracic and cardiovascular surgery.
[201] E. Vamvakas,et al. White blood cell‐containing allogeneic blood transfusion, postoperative infection and mortality: a meta‐analysis of observational ‘before‐and‐after’ studies , 2004, Vox sanguinis.
[202] H. Fritz,et al. Biochemistry and applications of aprotinin, the kallikrein inhibitor from bovine organs. , 1983, Arzneimittel-Forschung.
[203] M. Ramsay,et al. Continuous Small-Dose Aprotinin Controls Fibrinolysis During Orthotopic Liver Transplantation , 1996, Anesthesia and analgesia.
[204] O. N. Okike,et al. The role of epsilon-aminocaproic acid in reducing bleeding after cardiac operation: a double-blind randomized study. , 1988, The Journal of thoracic and cardiovascular surgery.
[205] R. Prêtre,et al. Influence of aprotinin on early graft thrombosis in patients undergoing myocardial revascularization. , 1994, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[206] Z. Straka,et al. Fibrinolytic inhibitors in off-pump coronary surgery: a prospective, randomized, double-blind TAP study (tranexamic acid, aprotinin, placebo). , 2005, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[207] A. Peral,et al. [Use of high doses of aprotinin in cardiac surgery]. , 1994, Revista espanola de anestesiologia y reanimacion.
[208] E. Berreklouw,et al. Low-dose aprotinin in internal mammary artery bypass operations contributes to important blood saving. , 1992, The Annals of thoracic surgery.
[209] M. Petricevic,et al. Tranexamic acid reduces postbypass blood use: a double-blinded, prospective, randomized study of 210 patients. , 1996, The Annals of thoracic surgery.
[210] Evert de Jonge,et al. Pharmacological strategies to decrease excessive blood loss in cardiac surgery: a meta-analysis of clinically relevant endpoints , 1999, The Lancet.
[211] N. Blumberg,et al. Allogeneic transfusion and infection: economic and clinical implications. , 1997, Seminars in hematology.
[212] S. Bélisle,et al. Randomized, Placebo‐Controlled, Double‐Blind Study of an Ultra‐Low‐Dose Aprotinin Regimen in Reoperative and/or Complex Cardiac Operations , 1997, Journal of cardiac surgery.
[213] P. Ffrench,et al. Reduction in blood loss and blood use after cardiopulmonary bypass with high-dose aprotinin versus autologous fresh whole blood transfusion. , 1992, Journal of cardiothoracic and vascular anesthesia.
[214] R. Poston,et al. A Randomized Clinical Trial Investigating the Relationship Between Aprotinin and Hypercoagulabilityin Off-Pump Coronary Surgery , 2009, Anesthesia and analgesia.
[215] G. Hill,et al. Aprotinin enhances the endogenous release of interleukin-10 after cardiac operations. , 1998, The Annals of thoracic surgery.
[216] D. Haskard,et al. Leukocyte integrin expression in patients undergoing cardiopulmonary bypass. , 2000, The Annals of thoracic surgery.
[217] S. Bélisle,et al. Prophylactic Tranexamic Acid and ϵ-Aminocaproic Acid for Primary Myocardial Revascularization , 1998 .
[218] R. Emery,et al. Decreased postoperative drainage with addition of ϵ-aminocaproic acid before cardiopulmonary bypass , 1994 .
[219] J. Ylinen,et al. Tranexamic acid (Cyklokapron) reduces perioperative blood loss associated with total knee arthroplasty , 1995 .
[220] O. Pradier,et al. Effects of aprotinin on blood loss, heparin monitoring tests, and heparin doses in patients undergoing coronary artery bypass surgery. , 1995, Journal of cardiothoracic and vascular anesthesia.
[221] A. McDonald,et al. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial , 2010, The Lancet.
[222] J. Copeland,et al. Aprotinin for primary coronary artery bypass grafting: a multicenter trial of three dose regimens. , 1996, The Annals of thoracic surgery.
[223] A. Laupacis,et al. A Meta-analysis of the Effectiveness of Cell Salvage to Minimize Perioperative Allogeneic Blood Transfusion in Cardiac and Orthopedic Surgery , 1999 .
[224] S. Shafer. Shadow of doubt. , 2011, Anesthesia and analgesia.
[225] J. Fehrenbacher,et al. The use of tranexamic acid to reduce postoperative bleeding following cardiac surgery: a double-blind randomized trial. , 1995, The American surgeon.
[226] M. Jochum,et al. Influence of high-dose aprotinin treatment on blood loss and coagulation patterns in patients undergoing myocardial revascularization. , 1990, Anesthesiology.
[227] A. Michelson,et al. Aprotinin reduces cardiopulmonary bypass‐induced blood loss and inhibits fibrinolysis without influencing platelets , 1993, British journal of haematology.
[228] S. Yamasaki,et al. Tranexamic acid reduces blood loss after cementless total hip arthroplasty—prospective randomized study in 40 cases , 2004, International Orthopaedics.
[229] L. Lorente,et al. Factors associated with excessive bleeding in cardiopulmonary bypass patients , 2006, Critical Care.
[230] S. Lethagen,et al. The effect of tranexamic acid on local and plasma fibrinolysis during total knee arthroplasty. , 1997, Thrombosis research.
[231] J. Wickham,et al. The prevention of secondary haemorrhage after prostatectomy: the value of antifibrinolytic therapy. , 1980, British journal of urology.
[232] L. Rossaro,et al. Aprotinin efficacy on intraoperative bleeding and transfusion requirements in orthotopic liver transplantation , 1994, Transfusion.
[233] O. Alfieri,et al. Tranexamic acid in off-pump coronary surgery: a preliminary, randomized, double-blind, placebo-controlled study. , 2001, The Annals of thoracic surgery.
[234] J. Webster,et al. Prospective randomized placebo‐controlled trial of aprotinin for elective aortic reconstruction , 1997, The British journal of surgery.
[235] J. Campistol,et al. Kidney‐specific proteins in patients receiving aprotinin at high‐ and low‐dose regimens during coronary artery bypass graft with cardiopulmonary bypass , 2005, European journal of anaesthesiology.
[236] A. Trowbridge,et al. Recombinant aprotinin in coronary artery bypass graft operations. , 1995, The Journal of thoracic and cardiovascular surgery.
[237] M. Jochum,et al. Influence of High-dose Aprotinin on Anticoagulation, Heparin Requirement, and Celite- and Kaolin-Activated Clotting Time in Heparin-pretreated Patients Undergoing Open-Heart Surgery: A Double-blind, Placebo-controlled Study , 1995, Anesthesiology.
[238] H. Sadeghi,et al. Tranexamic acid reduces blood loss and transfusion in reoperative cardiac surgery , 1997, Canadian journal of anaesthesia = Journal canadien d'anesthesie.
[239] John D Seeger,et al. Aprotinin during coronary-artery bypass grafting and risk of death. , 2008, The New England journal of medicine.
[240] M. Topbaş,et al. Effects of Minimal Dose Aprotinin on Blood Loss and Fibrinolytic System‐Complement Activation in Coronary Artery Bypass Grafting Surgery , 2006, Journal of cardiac surgery.
[241] B. Bidstrup,et al. Aprotinin and tranexamic acid in high‐transfusion‐risk cardiac surgery , 2006, Transfusion.
[242] Jianhua Yu,et al. [Clinical comparative studies on effect of tranexamic acid on blood loss associated with total knee arthroplasty]. , 2007, Zhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery.
[243] R. Adamson,et al. Effect of prophylactic epsilon-aminocaproic acid on blood loss and transfusion requirements in patients undergoing first-time coronary artery bypass grafting , 1994 .
[244] J. Soria,et al. Hemostasis in Patients Undergoing Extracorporeal Circulation: The Effect of Aprotinin (Trasylol) , 1991, Thrombosis and Haemostasis.
[245] R. Weisel,et al. Aprotinin and dipyridamole for the safe reduction of postoperative blood loss. , 1998, The Annals of thoracic surgery.
[246] C D Deakin,et al. Reducing allogeneic transfusion in cardiac surgery: a randomized double-blind placebo-controlled trial of antifibrinolytic therapies used in addition to intra-operative cell salvage. , 2005, British journal of anaesthesia.
[247] C. A. Jones,et al. The effect of epsilon aminocaproic acid on blood loss in patients who undergo primary total hip replacement: a pilot study. , 2002, Canadian journal of surgery. Journal canadien de chirurgie.
[248] R. Jedeikin,et al. The effect of tourniquet application, tranexamic acid, and desmopressin on the procoagulant and fibrinolytic systems during total knee replacement. , 2001, Journal of clinical anesthesia.
[249] E. Jaurrieta,et al. Comparative study of antifibrinolytic drugs in orthotopic liver transplantation. , 1999, Transplantation proceedings.
[250] M. Misfeld,et al. Fibrinolysis-adjusted perioperative low-dose aprotinin reduces blood loss in bypass operations. , 1998, The Annals of thoracic surgery.
[251] G. Mayer,et al. Lower cardiac troponin T levels in patients undergoing cardiopulmonary bypass and receiving high-dose aprotinin therapy indicate reduction of perioperative myocardial damage. , 1995, The Journal of thoracic and cardiovascular surgery.
[252] J. Findlay,et al. Aprotinin reduces red blood cell transfusion in orthotopic liver transplantation: A prospective, randomized, double‐blind study , 2001, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[253] M. V. Van Dyck,et al. Systematic use of aprotinin in cardiac surgery: influence on total homologous exposure and hospital cost. , 1992, Acta anaesthesiologica Belgica.
[254] F. D'Amico,et al. The Effect of Prophylactic ε-Aminocaproic Acid on Bleeding, Transfusions, Platelet Function, and Fibrinolysis during Coronary Artery Bypass Grafting , 1999 .
[255] H. Fredin,et al. Fibrinolytic inhibition with tranexamic acid reduces blood loss and blood transfusion after knee arthroplasty: a prospective, randomised, double-blind study of 86 patients. , 1996, The Journal of bone and joint surgery. British volume.
[256] W. van Oeveren,et al. Effects of aprotinin on hemostatic mechanisms during cardiopulmonary bypass. , 1987, The Annals of thoracic surgery.
[257] F. Sellke,et al. Aprotinin in cardiac surgery , 2006, Expert review of cardiovascular therapy.
[258] S. Braun,et al. High-dose aprotinin modulates the balance between proinflammatory and anti-inflammatory responses during coronary artery bypass graft surgery. , 2000, Journal of cardiothoracic and vascular anesthesia.
[259] S. Thompson,et al. Quantifying heterogeneity in a meta‐analysis , 2002, Statistics in medicine.
[260] A. Shirdel,et al. Tranexamic acid reduces blood loss in off-pump coronary artery bypass surgery. , 2009, Journal of cardiothoracic and vascular anesthesia.
[261] M. Pfisterer,et al. Aprotinin in Aortocoronary Bypass Surgery: Increased Risk of Vein-Graft Occlusion and Myocardial Infarction? Supportive Evidence from a Retrospective Study , 1996, Thrombosis and Haemostasis.
[262] C. Tatooles,et al. Aprotinin for coronary bypass operations: efficacy, safety, and influence on early saphenous vein graft patency. A multicenter, randomized, double-blind, placebo-controlled study. , 1994, The Journal of thoracic and cardiovascular surgery.
[263] K. Filos,et al. Influence of ultra-low dose Aprotinin on thoracic surgical operations: a prospective randomized trial , 2008, Journal of cardiothoracic surgery.
[264] P. Noris,et al. Platelet composition and function in patients undergoing cardiopulmonary bypass for heart surgery. , 1996, Haematologica.
[265] D. Benhamou,et al. Aprotinin Reduces Blood Loss in Patients Undergoing Elective Liver Resection , 1997, Anesthesia and analgesia.
[266] K. Hekmat,et al. Impact of tranexamic acid vs. aprotinin on blood loss and transfusion requirements after cardiopulmonary bypass: a prospective, randomised, double-blind trial , 2004 .
[267] R. McBroom,et al. Tranexamic Acid Reduces Perioperative Blood Loss in Adult Patients Having Spinal Fusion Surgery , 2008, Anesthesia and analgesia.
[268] W. Dick,et al. High-Dose ϵ-Aminocaproic Acid Versus Aprotinin: Antifibrinolytic Efficacy in First-Time Coronary Operations , 1998 .
[269] G. Laub,et al. The impact of aprotinin on coronary artery bypass graft patency. , 1994, Chest.
[270] A. Sandler,et al. Tranexamic Acid Reduces Blood Loss, Transfusion Requirements, and Coagulation Factor Use in Primary Orthotopic Liver Transplantation , 1996, Anesthesiology.
[271] J. Mahnken,et al. Heparin-bonded cardiopulmonary bypass circuits reduce the rate of red blood cell transfusion during elective coronary artery bypass surgery. , 2005, Journal of cardiothoracic and vascular anesthesia.
[272] G. Hill,et al. The Antiinflammatory Effects of Aprotinin in Patients Undergoing Cardiac Surgery with Cardiopulmonary Bypass , 1997, The Journal of ExtraCorporeal Technology.
[273] P. Grant,et al. Ultra-low dose aprotinin decreases transfusion requirements and is cost effective in coronary operations. , 2001, The Annals of thoracic surgery.
[274] J. Vincent,et al. cardiopulmonary bypass in patients , 2003 .
[275] A. Sturk,et al. Aprotinin preserves hemostasis in aspirin-treated patients undergoing cardiopulmonary bypass. , 1994, The Annals of thoracic surgery.
[276] S. Dzemeshkevich,et al. The use of high doses of aprotinin to decrease blood loss in aortocoronary by-pass surgery. , 1994, The Journal of cardiovascular surgery.
[277] R. Mohr,et al. Platelet protection by low-dose aprotinin in cardiopulmonary bypass: electron microscopic study. , 1993, The Annals of thoracic surgery.
[278] G. Watanabe,et al. Effect of tranexamic acid on blood loss reduction after cardiopulmonary bypass. , 2001, The Japanese journal of thoracic and cardiovascular surgery : official publication of the Japanese Association for Thoracic Surgery = Nihon Kyobu Geka Gakkai zasshi.
[279] H. Huwer,et al. Effects of high-dose aprotinin on renal function in aortocoronary bypass grafting. , 1995, The Annals of thoracic surgery.
[280] T. Misaki,et al. Effect of low-dose aprotinin on coagulation and fibrinolysis in cardiopulmonary bypass. , 1993, The Annals of thoracic surgery.
[281] J. Pickard,et al. The efficacy and safety of aprotinin for hemostasis during intracranial surgery. , 2003, Journal of neurosurgery.
[282] J. Breman,et al. Trends and risk factors for HIV-1 seropositivity among outpatient children, Kinshasa, Zaire. , 1990, AIDS (London).
[283] M. Sadeghi,et al. Does Tranexamic Acid Reduce Blood Loss in Off-Pump Coronary Artery Bypass? , 2007, Asian cardiovascular & thoracic annals.
[284] B. Griffith,et al. Aprotinin shows both hemostatic and antithrombotic effects during off-pump coronary artery bypass grafting. , 2006, The Annals of thoracic surgery.
[285] C. Bailey,et al. Randomized placebo‐controlled double‐blind study of three aprotinin regimens in primary cardiac surgery , 1994, British Journal of Surgery.
[286] J. Rauwerda,et al. Aprotinin Does Not Diminish Blood Loss in Elective Operations for Infrarenal Abdominal Aneurysms: A Randomized Double-Blind Controlled Trial , 2006, Annals of vascular surgery.
[287] Lee,et al. Economic analysis of erythropoietin use in orthopaedic surgery , 1999, Transfusion medicine.
[288] R. Suojaranta-Ylinen,et al. Tranexamic acid does not correct the haemostatic impairment caused by hydroxyethyl starch (200 kDa/0.5) after cardiac surgery , 2006, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.
[289] A. Lawrence,et al. The effect of epsilon aminocaproic acid on the blood loss after retropubic prostatectomy. , 1966, British journal of urology.
[290] B. Amsel,et al. Efficacy and safety of aprotinin in aortocoronary bypass and valve replacement operations: a placebo-controlled randomized double-blind study , 1996, Perfusion.
[291] R. Sapsford,et al. Amelioration of the bleeding tendency of preoperative aspirin after aortocoronary bypass grafting. , 2000, The Annals of thoracic surgery.
[292] L. Good,et al. Tranexamic acid decreases external blood loss but not hidden blood loss in total knee replacement. , 2003, British journal of anaesthesia.
[293] G. Ruvolo,et al. Changes in coagulation patterns, blood loss and blood use after cardiopulmonary bypass: aprotinin vs tranexamic acid vs epsilon aminocaproic acid. , 1996, The Journal of cardiovascular surgery.
[294] P. Mongan,et al. Tranexamic Acid Is Effective in Decreasing Postoperative Bleeding and Transfusions in Primary Coronary Artery Bypass Operations: A Double-Blind, Randomized, Placebo-Controlled Trial , 1997, Anesthesia and Analgesia.
[295] P. Brady,et al. The use of ultra-low-dose aprotinin to reduce blood loss in cardiac surgery. , 1995, Journal of cardiothoracic and vascular anesthesia.
[296] S. Bélisle,et al. Low-dose aprotinin infusion is not clinically useful to reduce bleeding and transfusion of homologous blood products in high-risk cardiac surgical patients , 1993, Canadian journal of anaesthesia = Journal canadien d'anesthesie.
[297] O. N. Okike,et al. Reduction of bleeding after heart operations through the prophylactic use of epsilon-aminocaproic acid. , 1996, The Journal of thoracic and cardiovascular surgery.
[298] J. Boldt,et al. The influence of aprotinin and tranexamic acid on platelet function and postoperative blood loss in cardiac surgery. , 2008, Anesthesia and analgesia.
[299] R. B. Smith,et al. Epsilon aminocaproic acid and the control of post-prostatectomy bleeding: a prospective double-blind study. , 1984, The Journal of urology.
[300] A. Laupacis,et al. Economic evaluations of technologies to minimize perioperative transfusion: a systematic review of published studies. International Study of Peri-operative Transfusion (ISPOT) investigators. , 1999, Transfusion medicine reviews.
[301] M. Licker,et al. Aprotinin does not impair renal haemodynamics and function after cardiac surgery. , 2000, British journal of anaesthesia.
[302] J. Andreasen,et al. Prophylactic tranexamic acid in elective, primary coronary artery bypass surgery using cardiopulmonary bypass. , 2004, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[303] E. Jaurrieta,et al. The prophylactic effect of aprotinin on intraoperative bleeding in liver transplantation: A randomized clinical study , 1997, Hepatology.
[304] W. Mcfarland,et al. Epidemiology and Prevention of Transfusion‐Associated Human Immunodeficiency Virus Transmission in Sub‐Saharan Africa , 1997, Vox sanguinis.
[305] A. Laupacis,et al. TECHNOLOGIES TO MINIMIZE BLOOD TRANSFUSION IN CARDIAC AND ORTHOPEDIC SURGERY , 1999, International Journal of Technology Assessment in Health Care.
[306] D. Royston. Aprotinin versus lysine analogues: the debate continues. , 1998, The Annals of thoracic surgery.
[307] T. Carrel,et al. Is reduced systemic heparinization justified with heparin-bonded bypass circuits in cardiac surgery?--Experience with and without aprotinin. , 2003, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.
[308] R. Sapsford,et al. Effect of aprotinin (Trasylol) on aorta-coronary bypass graft patency. , 1993, The Journal of thoracic and cardiovascular surgery.
[309] G. Laufer,et al. Operations on the thoracic aorta and hypothermic circulatory arrest: is aprotinin safe? , 1998, The Journal of thoracic and cardiovascular surgery.
[310] S. Guzzinati,et al. Tranexamic acid in aortic valve replacement. , 2001, Journal of cardiothoracic and vascular anesthesia.
[311] O. Boachie-Adjei,et al. The Efficacy of Antifibrinolytics in the Reduction of Blood Loss During Complex Adult Reconstructive Spine Surgery , 2001, Spine.
[312] Z. Straka,et al. Tranexamic acid reduces bleeding after off-pump coronary artery bypass grafting. , 2003, The Journal of cardiovascular surgery.